Ifebemtinib and paclitaxel synergistically inhibit the proliferation and metastasis of TNBC by blocking PI3K/Akt pathway through LSD1/PIK3IP1 axis.
Saved in:
| Title: | Ifebemtinib and paclitaxel synergistically inhibit the proliferation and metastasis of TNBC by blocking PI3K/Akt pathway through LSD1/PIK3IP1 axis. |
|---|---|
| Authors: | Li, Yong1 (AUTHOR), Li, Lianfang1 (AUTHOR), Mao, Qixin1 (AUTHOR), Liu, Shanqing1 (AUTHOR), Shen, Yan1 (AUTHOR), Zhao, Wanying2 (AUTHOR), Zheng, Shaohua3 (AUTHOR), Wang, Sai-Qi3 (AUTHOR), Chen, Xiao-Bing3 (AUTHOR) zlyychenxb0807@zzu.edu.cn |
| Source: | Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
